List of largest pharmaceutical settlements

List of Largest Pharmaceutical Settlements

The List of Largest Pharmaceutical Settlements refers to the highest monetary agreements reached between pharmaceutical companies and various legal entities, often as a result of lawsuits or regulatory actions. These settlements often involve allegations of illegal marketing practices, fraud, or other violations of federal laws.

Overview

Pharmaceutical settlements are often the result of legal actions taken against pharmaceutical companies for various reasons. These can include allegations of off-label marketing, failure to disclose known side effects, fraudulent pricing practices, or violations of the False Claims Act. The settlements are typically monetary and can range from millions to billions of dollars.

Notable Settlements

GlaxoSmithKline

In 2012, GlaxoSmithKline agreed to a $3 billion settlement with the U.S. government over allegations of illegal marketing practices and failure to report safety data. This remains the largest pharmaceutical settlement in history.

Pfizer

In 2009, Pfizer agreed to a $2.3 billion settlement over allegations of off-label marketing and kickbacks. This was the largest healthcare fraud settlement in the history of the Department of Justice.

Johnson & Johnson

In 2013, Johnson & Johnson agreed to a $2.2 billion settlement over allegations of off-label marketing and kickbacks. This was one of the largest healthcare fraud settlements in U.S. history.

See Also

• Pharmaceutical industry
• Off-label use
• False Claims Act
• Healthcare fraud

References

This article is a stub related to pharmacology. You can help WikiMD by expanding it!